Volume 6 Issue 12, Dec 2021

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)

Volume 6 Issue 12, Dec 2021:
Review Article
The JAK/STAT signaling pathway: from bench to clinic
Xiaoyi Hu  ORCID: orcid.org/0000-0002-2786-4234,Jing li,Maorong Fu,Xia Zhao &…Wei Wang  ORCID: orcid.org/0000-0001-7788-1895 
The Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling pathway was discovered more than a quarter-century ago. As a fulcrum of many vital cellular processes, the JAK/STAT pathway constitutes a rapid membrane-to-nucleus signaling module and induces the expression of various critical mediators of cancer and inflammation. Growing evidence suggests that dysregulation of the JAK/STAT pathway is associated with various cancers and autoimmune diseases. In this review, we discuss the current knowledge about the composition, activation, and regulation of the JAK/STAT pathway. Moreover, we highlight the role of the JAK/STAT pathway and its inhibitors in various diseases.